Renalytix Plc ADR [NASDAQ: RNLX] jumped around 0.02 points on Friday, while shares priced at $0.31 at the close of the session, up 7.31%.
Compared to the average trading volume of 1.94M shares, RNLX reached a trading volume of 15075591 in the most recent trading day, which is why market watchdogs consider the stock to be active.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
What do top market gurus say about Renalytix Plc ADR [RNLX]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for RNLX shares is $3.46 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on RNLX stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
H.C. Wainwright have made an estimate for Renalytix Plc ADR shares, keeping their opinion on the stock as Buy, with their previous recommendation back on January 18, 2022. While these analysts kept the previous recommendation, BTIG Research raised their target price to Buy. The new note on the price target was released on January 04, 2022, representing the official price target for Renalytix Plc ADR stock. Previously, the target price had yet another raise to $28, while Guggenheim analysts kept a Buy rating on RNLX stock.
The Average True Range (ATR) for Renalytix Plc ADR is set at 0.05, with the Price to Sales ratio for RNLX stock in the period of the last 12 months amounting to 11.73.
How has RNLX stock performed recently?
Renalytix Plc ADR [RNLX] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -2.79. With this latest performance, RNLX shares dropped by -24.41% in over the last four-week period, additionally sinking by -69.81% over the last 6 months – not to mention a drop of -89.74% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for RNLX stock in for the last two-week period is set at 44.31, with the RSI for the last a single of trading hit 42.67, and the three-weeks RSI is set at 44.95 for Renalytix Plc ADR [RNLX]. The present Moving Average for the last 50 days of trading for this stock 0.3375, while it was recorded at 0.3196 for the last single week of trading, and 0.5428 for the last 200 days.
Renalytix Plc ADR [RNLX]: Deeper insight into the fundamentals
Renalytix Plc ADR’s liquidity data is similarly interesting compelling, with a Quick Ratio of 0.42 and a Current Ratio set at 0.42.
Insider trade positions for Renalytix Plc ADR [RNLX]
The top three institutional holders of RNLX stocks are: PINNACLE ASSOCIATES LTD with ownership of 0.82 million shares, which is approximately 1.67%. STIFEL FINANCIAL CORP, holding 0.56 million shares of the stock with an approximate value of $$0.13 million in RNLX stocks shares; and STIFEL FINANCIAL CORP, currently with $$0.13 million in RNLX stock with ownership which is approximately 1.1367%.
